abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

Esta página no está disponible en Español y está siendo mostrada en English

Artículo

22 Jul 2021

Autor:
Evan Simko-Bednarski, CNN (USA)

USA: McKesson, Cardinal, & Amerisource Bergen settle New York state opioid lawsuit for $1.1 billion

"Three opioid distributors settle New York lawsuit for $1.1 billion", 20 Jul 2021

Three opioid distributors have settled a lawsuit with New York state to the tune of over $1 billion...

McKesson Corporation, Cardinal Health Inc. and Amerisource Bergen Drug Corporation have agreed to pay $1.1 billion towards opioid abatement efforts in the Empire State, according to the statement.

This effectively ends their participation in an ongoing civil suit in New York...

The money will be paid out over the course of the next 17 years, with the first payment coming in September.

The three distributors have also agreed to monitoring of their opioid shipments going forward, with a third-party, independent watchdog overseeing pharmacy-level distribution data pooled among the three companies.

McKesson, Cardinal, and Amerisource Bergen were sued by the State of New York in 2019, part of a sweeping lawsuit against a long slate of pharmaceutical manufacturers and distributors. At the time, James accused the companies of engaging in "years of deceptive marketing about the risks of opioids and (failure) to exercise their basic duty to report suspicious behavior."

Johnson & Johnson settled with the state last month, paying $230 million to resolve the suit. Several other defendants in the initial suit, including Purdue Pharma and distributor Rochester Drug Cooperative, have declared bankruptcy, and the cases against them are moving through the bankruptcy court system.

Three additional opioid manufacturers -- Endo Health Solutions, Teva Pharmaceuticals USA, Inc. and Allergan Finance, LLC -- continue to contest the state's claims at trial.

Línea del tiempo

Información de privacidad

Este sitio usa cookies y otras tecnologías de almacenamiento web. Puede configurar sus preferencias de privacidad más adelante. Los cambios se aplicarán de inmediato.

Para más información sobre el uso que hacemos del almacenamiento web, por favor consulte nuestra Política de Cookies y Uso de Datos

Strictly necessary storage

ON
OFF

Necessary storage enables core site functionality. This site cannot function without it, so it can only be disabled by changing settings in your browser.

Cookies analíticas

ON
OFF

Cuando accede a nuestro sitio web, utilizamos Google Analytics para recopilar información sobre su visita. La aceptación de esta cookie nos permitirá conocer más detalles sobre su visita y mejorar la forma en que mostramos la información. Toda la información analítica es anónima y no la utilizamos para identificarle. Google proporciona un complemento de inhabilitación de Google Analytics para todos los navegadores populares.

Cookies promocionales

ON
OFF

Compartimos noticias y actualizaciones sobre empresas y derechos humanos a través de plataformas de terceros, incluidas las redes sociales y los motores de búsqueda. Estas cookies nos ayudan a comprender el rendimiento de estas promociones.

Sus preferencias de privacidad en este sitio

Este sitio usa cookies y otras tecnologías de almacenamiento web para mejorar su experiencia, mas allá de la funcionalidad básica necesaria.